Management of Positive HPV Test on Pap Smear

Initial Management

For patients with HPV-positive results and normal cytology, the Centers for Disease Control and Prevention recommends repeat HPV testing with or without concurrent Pap test in 1 year if it's the first positive HPV test 1, 2
If it's a second consecutive positive HPV test, immediate colposcopy is recommended regardless of previous Pap test results, as per the Centers for Disease Control and Prevention guidelines 1, 3
For HPV-positive results with abnormal cytology, such as ASC-US or LSIL, immediate colposcopy is generally recommended by the American Society for Colposcopy and Cervical Pathology 1, 3
The American College of Obstetricians and Gynecologists recommends immediate colposcopy for HPV genotyping positive for types 16 or 18, even with normal cytology, due to higher cancer risk 2, 4

For HPV 16, which is the highest-risk HPV type, expedited treatment is preferred for non-pregnant patients aged ≥25 years with HSIL cytology, according to the American Society for Colposcopy and Cervical Pathology 4
For HPV 18, which has a high association with adenocarcinoma, colposcopy is recommended in all cases, even with normal cytology, as per the American College of Obstetricians and Gynecologists 4

The American Cancer Society recommends HPV testing or cotesting over cytology alone for follow-up after abnormal results, as it is less likely to miss disease than normal cytology alone 4
After treatment for high-grade precancer, surveillance should continue for at least 25 years, with initial testing including HPV test or cotest at 6, 18, and 30 months, as recommended by the American Society for Colposcopy and Cervical Pathology 4

The Centers for Disease Control and Prevention advises against dismissing HPV-positive results with normal cytology, as persistent HPV infection is a significant risk factor for developing cervical cancer 1, 2
A patient's history of high-grade lesions may warrant colposcopy regardless of current results, according to the American College of Obstetricians and Gynecologists 1

The American College of Obstetricians and Gynecologists recommends that patients who have remained persistently HPV-positive over 5 years should undergo immediate colposcopy, as their 10-year cumulative risk of CIN3+ is approximately 20.4% 5
If a patient has had any negative HPV tests in the intervening 5 years, they should return to routine screening intervals, with cotesting every 5 years for ages 30-65, as recommended by the American Cancer Society 5, 6

The American Cancer Society advises that a prolonged period of HPV carriage required for invasive cancer development means that 5 years of potential persistence represents significant risk, with approximately 63% of adenocarcinomas diagnosed over 5-year periods following an HPV-positive, cytology-negative cotest 5
Approximately 20.4% of patients with persistent HPV infection over 5 years will develop CIN3+, highlighting the need for immediate colposcopy, as recommended by the American College of Obstetricians and Gynecologists 5

The American Cancer Society states that negative HPV testing provides reassurance for at least 5 years, with a cumulative CIN3+ risk of only 0.31% over 10 years following a negative HPV test, based on high-quality evidence 5

The British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology recommend two consecutive high-risk HPV negative tests 12 months apart to return to routine 3-year recall intervals 7, 8, 9
Women who have achieved HPV clearance require one additional HPV test 12 months after their first negative test, and if negative, can be discharged to routine screening with the next test in 3 years 7, 10
If an HPV test returns positive after clearance, immediate colposcopy is recommended regardless of cytology results, due to the history of previous HPV positivity 7, 9, 10
The American Society for Colposcopy and Cervical Pathology emphasizes that HPV clearance does not automatically eliminate pre-existing dysplastic lesions, and two consecutive negative HPV tests 12 months apart must be completed before extending screening intervals 7, 8
If any future HPV test returns positive after discharge, immediate referral to colposcopy is mandatory, regardless of cytology results, due to the heightened risk conferred by previous HPV positivity 7, 9

The American College of Obstetricians and Gynecologists notes that a negative colposcopy only evaluates morphological alterations of the cervix, not the presence or absence of HPV at a molecular level 11
Approximately 60% of high-risk HPV infections spontaneously clear within 12 months, but this means that 40% persist beyond this period, according to the National Comprehensive Cancer Network 11

Coinfections with Chlamydia trachomatis and Candida do not necessarily accelerate HPV clearance, but treatment of these infections may have contributed to the regression of visible cytological lesions, as suggested by the National Comprehensive Cancer Network 11

After a negative colposcopy for LSIL, guidelines recommend an HPV test at 12 months to determine if the virus persists, as stated by the National Comprehensive Cancer Network 11